Olmecar® Plus

Olmesartan Medoxomil + Hydrochlorothiazide
AT1 receptor blocker combination (Cardiovascular Preparations)

Indication:
Indicated for the treatment of hypertension. This ¬fixed dose combination is not indicated for initial therapy.

Dosage & Administration:
The recommended dose is one OlmecarTM Plus 20/12.5 tablet a day. However, if the blood pressure is not controlled, then, as per the doctor's recommendation, the dose can be increased. Swallow the tablet with water at the same time each day. It is important to continue taking OlmecarTM Plus 20/12.5 tablet until the doctor tells you to stop.
Patients with Renal Impairment: The usual regimens of therapy with OlmecarTM Plus 20/12.5 tablet may be followed provided the patient's creatinine clearance>30 ml/min. In patients with more severe renal impairment, loop diuretics are preferred to thiazides, so this combination tablet is not recommended. Patients with Hepatic Impairment: No dosage adjustment is necessary with hepatic impairment.

Preparation:
 OlmecarTM Plus 20/12.5 Tablet: Each box contains 30 tablets in blister pack.



  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides